Table 3.
IOD (mean) of Cx43 in the biopsy of CML patients and healthy donors.
| Patients | Gender | Age (years) | Diagnosis | IOD (mean) | Donor | Gender | Age (years) | IOD (mean) |
| Patient 1 | M | 20 | CML | 623.91 | Donor 1 | F | 53 | 2185.22 |
| Patient 2 | M | 22 | CML | 1710.89 | Donor 2 | F | 44 | 2166.52 |
| Patient 3 | F | 28 | CML | 561.67 | Donor 3 | F | 61 | 5368.76 |
| Patient 4 | F | 54 | CML | 2002.27 | Donor 4 | F | 20 | 7650.07 |
| Patient 5 | F | 58 | CML | 2935.38 | Donor 5 | M | 37 | 5184.72 |
| Patient 6 | M | 75 | CML | 4271.85 | Donor 6 | M | 52 | 7020.30 |
| Patient 7 | F | 26 | CML | 1975.45 | Donor 7 | M | 32 | 8386.25 |
| Patient 8 | M | 64 | CML | 2239.86 | Donor 8 | M | 48 | 3190.83 |
| Patient 9 | F | 35 | CML | 6473.38 | Donor 9 | F | 55 | 2056.72 |
| Patient 10 | M | 57 | CML | 631.65 | Donor 10 | F | 25 | 2532.66 |
CML: Chronic myeloid leukemia; Cx43: Connexin 43; F: Female; IOD: Integral optical intensity; M: Male.